APA

Müller B. M., Jana L., Kasajima A., Lehmann A., Prinzler J., Budczies J., Winzer K., Dietel M., Weichert W. & Denkert C. (20140110). Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. : BMC cancer.

Chicago

Müller Berit Maria, Jana Lisa, Kasajima Atsuko, Lehmann Annika, Prinzler Judith, Budczies Jan, Winzer Klaus-Jürgen, Dietel Manfred, Weichert Wilko and Denkert Carsten. 20140110. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. : BMC cancer.

Harvard

Müller B. M., Jana L., Kasajima A., Lehmann A., Prinzler J., Budczies J., Winzer K., Dietel M., Weichert W. and Denkert C. (20140110). Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. : BMC cancer.

MLA

Müller Berit Maria, Jana Lisa, Kasajima Atsuko, Lehmann Annika, Prinzler Judith, Budczies Jan, Winzer Klaus-Jürgen, Dietel Manfred, Weichert Wilko and Denkert Carsten. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. : BMC cancer. 20140110.